Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Guardant Health Inc (NASDAQ: GH) closed at $44.97 in the last session, down -0.46% from day before closing price of $45.18. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 1.82 million shares were traded. GH stock price reached its highest trading level at $45.11 during the session, while it also had its lowest trading level at $43.94.
Ratios:
We take a closer look at GH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.68.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $55.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $60.
Guggenheim Upgraded its Neutral to Buy on June 28, 2024, while the target price for the stock was maintained at $36.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 17 ’25 when Tariq Musa bought 116 shares for $44.79 per share.
Tariq Musa sold 116 shares of GH for $5,069 on Mar 19 ’25. The Director now owns 3,211 shares after completing the transaction at $43.70 per share. On Mar 19 ’25, another insider, Tariq Musa, who serves as the Director of the company, bought 116 shares for $43.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5550242304 and an Enterprise Value of 6046336000. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.51. Its current Enterprise Value per Revenue stands at 8.182 whereas that against EBITDA is -15.07.
Stock Price History:
The Beta on a monthly basis for GH is 1.43, which has changed by 1.798382 over the last 52 weeks, in comparison to a change of 0.0635103 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $50.89, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 3.17%, while the 200-Day Moving Average is calculated to be 33.62%.
Shares Statistics:
According to the various share statistics, GH traded on average about 2.33M shares per day over the past 3-months and 2124320 shares per day over the past 10 days. A total of 123.99M shares are outstanding, with a floating share count of 117.04M. Insiders hold about 5.17% of the company’s shares, while institutions hold 96.16% stake in the company. Shares short for GH as of 1743379200 were 8281364 with a Short Ratio of 3.56, compared to 1740700800 on 7897769. Therefore, it implies a Short% of Shares Outstanding of 8281364 and a Short% of Float of 6.99.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
